The SLC7A14 gene helps move certain amino acids inside lysosomes, the cell’s recycling compartments, especially in the retina and inner ear. This gene plays an important role in helping sensory cells clear waste and stay healthy over time. If the SLC7A14 gene does not work properly, these cells may gradually stop working, which can lead to inherited vision loss and, in some people, hearing loss. Most people learn about SLC7A14 through genetic testing for retinal conditions rather than from media coverage or public figures.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or direct processes in the body. Some genes carry the directions for building proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
SLC7A14Gene function
What if the gene works
The SLC7A14 gene helps certain eye and inner ear cells move the amino acid arginine inside recycling compartments called lysosomes. This supports normal cell upkeep, especially in cells involved in vision and hearing.
Risk
What if the gene does not work
Variants in the SLC7A14 gene are linked mainly to inherited retinal degeneration, often causing night blindness and narrowing vision that can worsen over time. Milder and more severe variants can affect when symptoms begin and how much vision is lost.
Treatment
What does that mean for your treatment
No SLC7A14-specific treatment or management approach is currently established in clinical guidelines. At present, a pathogenic or loss-of-function variant in the SLC7A14 gene does not guide a specific drug choice, so care is based on the person’s symptoms and standard supportive management.
Conditions associated with SLC7A14
Gene function
What if the gene works
Inside your cells, old materials are regularly broken down and reused. The SLC7A14 gene helps this process by making a transporter in lysosomes, the cell compartments that act like recycling centers. Its main job is to move certain positively charged amino acids, especially arginine, across the lysosome membrane. This helps cells manage nutrients and routine maintenance.
The SLC7A14 gene makes a protein that sits in the lysosome membrane. It helps move positively charged amino acids, especially arginine, across that membrane so cells can reuse and manage these building blocks.
By controlling amino acid movement in lysosomes, this gene supports the cell’s cleanup and recycling system. That helps cells recover useful parts from worn out material during everyday upkeep.
SLC7A14 gene function also helps maintain amino acid balance inside the cell. Keeping these nutrients in the right place supports steady cell activity and normal cellular maintenance.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body reacts to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC7A14 gene can change the protein’s shape, stability, or delivery to lysosomes, the cell’s recycling compartments, so it may work only partly or not at all. This is how variants in the SLC7A14 gene affect cell function: some reduce amino acid transport, while more disruptive variants can nearly abolish it and upset cell cleanup. In SLC7A14-related retinal disease, milder variants may be linked to later onset, while severe variants can be linked to earlier symptoms.
How variants are linked to conditions
Pathogenic variants in the SLC7A14 gene can cause autosomal recessive retinitis pigmentosa, an inherited eye condition that often begins with night blindness and a gradual loss of side vision. In clinical genetics, SLC7A14 gene variants linked to retinitis pigmentosa are the main well-established association for this gene. Some reported families have also had hearing changes, but the clearest and most broadly accepted link is to this form of inherited retinal disease.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, particularly when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For conditions linked to the SLC7A14 gene, risk is mainly set by the gene changes inherited from your parents. In families with two changed copies, symptoms can still vary, but there is not enough evidence that lifestyle changes lower the chance of developing the related eye condition; regular eye exams can help catch changes early.
Inheritance of SLC7A14 variants
SLC7A14-related disease is inherited in an autosomal recessive pattern. This means a person usually needs to inherit two disease-causing variants in the SLC7A14 gene, one from each parent, to be affected. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. Understanding how SLC7A14 gene variants are inherited can help explain why the condition may appear unexpectedly in a family.
What does my SLC7A14 result mean for my family?
For families with a disease-causing change in the SLC7A14 gene, the pattern is usually recessive, which means parents and other close relatives can be healthy carriers without knowing it. Brothers and sisters may also be carriers, and some may have the condition if they inherited the changed gene from both parents. Because of this, relatives may want to discuss family testing with a genetics professional, especially if there is vision loss or hearing problems in the family.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC7A14 gene, genetic testing reads DNA from a blood sample, saliva, or cheek swab. SLC7A14 genetic testing for inherited retinal disease is often done as part of a multigene panel or broader sequencing test. A lab compares your sequence with the usual code and reports whether a variant is found.
When should I consider getting a genetic test?
Consider testing for the SLC7A14 gene if you or your child has inherited vision loss, especially trouble seeing at night or slowly narrowing side vision, or if these problems run in the family. Testing can also make sense when a relative is known to carry an SLC7A14 variant.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains varies by the condition and the specific type of variant involved. Over time, many factors influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best viewed alongside the rest of a person’s care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else. Part of the reason is that genes can influence how the body breaks down, moves, or responds to a drug, and these inherited differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medicines. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the SLC7A14 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general questions about treatment, side effects, or changing symptoms are best discussed with your doctor.
History
Researchers identified the SLC7A14 gene as part of the larger solute carrier family during efforts to map genes involved in how cells move small molecules. Early work focused on where it was active in the body, especially in the eye and inner ear. Over time, descriptions became more precise. In the 2010s, studies linked variants in the SLC7A14 gene to inherited retinal disease, particularly forms of retinitis pigmentosa, and later reports connected it with hearing changes in some families. These findings moved the SLC7A14 gene from a little-known research target to a recognized gene in vision and hearing genetics.